Hexane

Hexane

SCHEMBL2790499

CCCCCC.C[N+](=O)[O-]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
TSHR P16473 3/20 0.47
THRB P10828 1/20 0.47
CES2 O00748 5/20 0.45
CES1 P23141 5/20 0.45
LMNA P02545 1/20 0.40
SLC22A1 O15245 2/20 0.37
SLC22A2 O15244 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
EPHX2 P34913 1/20 0.36
AKR1B1 P15121 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octane SCHEMBL8655397 0.97 ALDH1A1 (0.65) ALDH1A1TSHRTHRBCES2CES1
Pentane SCHEMBL26986723 0.93
Nitromethane SCHEMBL6387542 0.84 ALDH1A1 (0.52) ALDH1A1TSHRTHRBCES2CES1
Dodecane SCHEMBL28302235 0.83 ALDH1A1 (0.65) ALDH1A1TSHRTHRBCES2CES1
Hexane SCHEMBL10491880 0.83 ALDH1A1 (0.57) ALDH1A1TSHRTHRBCES2CES1
Hexane SCHEMBL27687689 0.83 ALDH1A1 (0.57) ALDH1A1TSHRTHRBCES2CES1
Butyl Alcohol SCHEMBL8416584 0.82
Nitromethane SCHEMBL28129155 0.81
Hexadecane SCHEMBL380459 0.80 ALDH1A1 (0.62) ALDH1A1TSHRTHRBCES2CES1
Hexane SCHEMBL29015104 0.80 ALDH1A1 (0.55) ALDH1A1TSHRTHRBCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108794342-A Ammonium carboxylate salt compound, its crystal form, amorphous substance and preparation method thereof 武汉朗来科技发展有限公司 2018-11-13 CN claimed
CN-108794342-A Ammonium carboxylate salt compound, its crystal form, amorphous substance and preparation method thereof 武汉朗来科技发展有限公司 2018-11-13 CN disclosed
CN-101283796-B Health product with walnut oil as matrix for treating osteoporosis and cardiovascular and cerebrovascular diseases MEDICAL DEV CO LTD OF KUNMING YUNNAN UNIVERSITY 2012-05-30 CN disclosed
WO-2010137032-A2 NOVEL POLYMORPHIC FORMS OF ELVITEGRAVIR AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS MATRIX LABORATORIES LTD. (IN) 2010-12-02 WO disclosed
CN-101283796-A Health products for osteoporosis and cardio-cerebrovascular disease using walnut oil as matrix MEDICAL DEV CO LTD (CN) 2008-10-15 CN disclosed